[1] SINGH A,TREVICK S. The epidemiology of global epilepsy[J]. Neurol Clin,2016,34(4):837-847.
[2] WANG W,WU J,LI S,et al. Sodium valproate for epilepsy in rural China:an efficacy and safety assessment in primary care[J]. Epilepsy Res,2012,102(3):201-205.
[3] 孙浩,徐英宏,杨振宇,等. 美罗培南致丙戊酸血药浓度显著降低的案例分析[J]. 中国医院药学杂志,2012,32(20):1651-1653.
[4] NAGAI K,SHIMIZU T,TOGO A,et al. Decrease in serum levels of valproic acid during treatment with a new carbapenem,panipenem/betamipron[J]. J AntimicrobChemother,1997,39(2):295-296.
[5] MANCL EE,GIDAL BE. The effect of carbapenem antibiotics on plasma concentrations of valproic acid[J]. Ann Pharmacother,2009,43(12):2082-2087.
[6] YOOH H,KIM DH. Unusual drug reaction between valproate sodium and meropenem[J]. Int J Clin Pharm,2013,35(3):316-318.
[7] PARK MK,LIM KS,KIM TE,et al. Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics:overview of 6 cases[J]. Ther Drug Monit,2012,34(5):599-603.
[8] WU CC,PAI TY,HSIAO FY,et al. The effect of different carbapenem antibiotics (ertapenem,imipenem/cilastatin,and meropenem) on serum valproic acid concentrations[J]. Ther Drug Monit,2016,38(5):587-592.
[9] WEN ZP,FAN SS,DU C,et al. Drug-drug interaction between valproic acid and meropenem:a retrospective analysis of electronic medical records from neurosurgery inpatients[J]. J Clin Pharm Ther,2017,4(2):221-227.
[10] CHEN YI,GOLDSTEIN JA. The transcriptional regulation of the human CYP2C genes[J]. Curr Drug Metab,2009,10(6):567-578.
[11] 闫佳佳,何秋毅. 丙戊酸钠血药浓度监测结果与影响因素分析[J].海峡药学,2014(8):151-152.
[12] 闫彩萍,郝润喜,孙美珍,等. 癫痫患儿联用苯巴比妥、丙戊酸钠时血药浓度分析[J]. 山西医科大学学报,2003,34(1):59-61.
[13] HANRATH MA,SWART EL. Convulsions due to an interaction between anti-epileptic drugs and rifampicin[J]. Ned Tijdschr Geneeskd,2014,158:A7707.
[14] 陈珲,蔡泓敏,冯端浩,等. CYP2C9和CYP2C19基因多态性对药物代谢的影响及个体化用药研究进展[J]. 中国药物应用与监测,2014,(4):240-244.
[15] 韩瑞玲,李艳,吴薇. 癫痫患者CYP2C19基因多态性对丙戊酸钠血药浓度的影响[J]. 神经损伤与功能重建,2015,10(4):295-297.